80 FR 12262 - Notice of Intent To Grant an Exclusive License

DEPARTMENT OF VETERANS AFFAIRS

Federal Register Volume 80, Issue 44 (March 6, 2015)

Page Range		12262-12262
FR Document		2015-05209

Notice is hereby given that the Department of Veterans Affairs, Office of Research and Development, intends to grant to Rubicon Biotechnology, LLC, 26212 Dimension Dr. Suite 260, Lake Forest, CA 92630, USA, an exclusive license to practice the following: U.S. Patent Application Serial No. 13/815,829 (``ANTIBODY-MEDIATED TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS''), filed March 15, 2013, which claimed the priority of U.S. Serial No. 61/618,594, filed March 30, 2012. Copies of the published patent applications may be obtained from the U.S. Patent and Trademark Office at www.uspto.gov.

Federal Register, Volume 80 Issue 44 (Friday, March 6, 2015)

[Federal Register Volume 80, Number 44 (Friday, March 6, 2015)]
[Notices]
[Page 12262]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-05209]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Notice of Intent To Grant an Exclusive License

AGENCY: Office of Research and Development, Department of Veterans 
Affairs.

ACTION: Notice of Intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Department of Veterans 
Affairs, Office of Research and Development, intends to grant to 
Rubicon Biotechnology, LLC, 26212 Dimension Dr. Suite 260, Lake Forest, 
CA 92630, USA, an exclusive license to practice the following: U.S. 
Patent Application Serial No. 13/815,829 (``ANTIBODY-MEDIATED 
TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS''), filed March 
15, 2013, which claimed the priority of U.S. Serial No. 61/618,594, 
filed March 30, 2012. Copies of the published patent applications may 
be obtained from the U.S. Patent and Trademark Office at www.uspto.gov.

DATES: Comments must be received 15 days from the date of this 
published Notice.

ADDRESSES: Written comments may be submitted through 
www.regulations.gov; by mail or hand-delivery to the Director, 
Regulations Management (02REG), Department of Veterans Affairs, 810 
Vermont Avenue NW., Room 1068, Washington, DC, 20420; or by fax to 
(202) 273-9026. Copies of comments received will be available for 
public inspection in the Office of Regulation Policy and Management, 
Room 1063B, between the hours of 8:00 a.m. and 4:30 p.m., Monday 
through Friday (except holidays). Call (202) 461-4902 for an 
appointment (this is not a toll-free number). In addition, during the 
comment period, comments may be viewed online through the Federal 
Docket Management System at http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Dr. Lee A. Sylvers, Technology 
Transfer Specialist, Office of Research and Development (10P9TT), 
Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC, 
20420, (202) 443-5646 (this is not a toll-free number).

SUPPLEMENTARY INFORMATION: It is in the public interest to so license 
these inventions, as Rubicon Biotechnology, LLC submitted a complete 
and sufficient application for a license. The prospective exclusive 
license will be royalty-bearing and will comply with the terms and 
conditions of 35 U.S.C. 209 and 37 CFR 404.7.

Signing Authority

    The Secretary of Veterans Affairs, or designee, approved this 
document and authorized the undersigned to sign and submit the document 
to the Office of the Federal Register for publication electronically as 
an official document of the Department of Veterans Affairs. Jose D. 
Riojas, Chief of Staff, approved this document on March 2, 2015 for 
publication.

    Approved: March 3, 2015.
Michael Shores,
Regulation Policy and Management, Office of General Counsel.
[FR Doc. 2015-05209 Filed 3-5-15; 8:45 am]
 BILLING CODE 8320-01-P

12262 Federal Register / Vol. 80, No. 44 / Friday, March 6, 2015 / Notices

and equitable allocation of securities (b) The accuracy of the OCC’s ADDRESSES: Written comments may be
and prices to accounts, and provide for estimate of the burden of the collection submitted through www.regulations.gov;
crossing of buy and sell orders on a fair of information; by mail or hand-delivery to the Director,
and equitable basis. (c) Ways to enhance the quality, Regulations Management (02REG),
• 12 CFR 151.140 requires Federal utility, and clarity of the information to Department of Veterans Affairs, 810
savings associations to adopt written be collected; Vermont Avenue NW., Room 1068,
policies and procedures dealing with (d) Ways to minimize the burden of Washington, DC, 20420; or by fax to
the functions involved in effecting the collection on respondents, including (202) 273–9026. Copies of comments
securities transactions on behalf of through the use of automated collection received will be available for public
customers. These policies and techniques or other forms of information inspection in the Office of Regulation
procedures must assign responsibility technology; and Policy and Management, Room 1063B,
for the supervision of employees who (e) Estimates of capital or start-up between the hours of 8:00 a.m. and 4:30
perform securities trading functions, costs and costs of operation, p.m., Monday through Friday (except
provide for the fair and equitable maintenance, and purchase of services holidays). Call (202) 461–4902 for an
allocation of securities prices to to provide information. appointment (this is not a toll-free
accounts, and provide for crossing of Dated: March 2, 2015. number). In addition, during the
buy and sell orders on a fair and comment period, comments may be
Stuart E. Feldstein,
equitable basis. viewed online through the Federal
Director, Legislative and Regulatory Activities
• 12 CFR 12.7(a)(4) requires certain Division.
Docket Management System at http://
national bank officers and employees www.regulations.gov.
[FR Doc. 2015–05154 Filed 3–5–15; 8:45 am]
involved in the securities trading FOR FURTHER INFORMATION CONTACT: Dr.
BILLING CODE 4810–33–P
process to report to the bank all Lee A. Sylvers, Technology Transfer
personal transactions in securities made Specialist, Office of Research and
by them or on their behalf in which they Development (10P9TT), Department of
have a beneficial interest. Veterans Affairs, 810 Vermont Avenue
DEPARTMENT OF VETERANS
• 12 CFR 151.150 requires certain NW., Washington, DC, 20420, (202)
AFFAIRS
Federal savings association officers and 443–5646 (this is not a toll-free
employees to report personal Notice of Intent To Grant an Exclusive number).
transactions they make or that are made License
on their behalf in which they have a SUPPLEMENTARY INFORMATION: It is in the
beneficial interest. AGENCY: Office of Research and public interest to so license these
• 12 CFR 12.8 requires a national Development, Department of Veterans inventions, as Rubicon Biotechnology,
bank seeking a waiver of one or more of Affairs. LLC submitted a complete and sufficient
the requirements of §§ 12.2 through 12.7 ACTION: Notice of Intent. application for a license. The
to file a written request for waiver with prospective exclusive license will be
the OCC. SUMMARY: Notice is hereby given that royalty-bearing and will comply with
Type of Review: Regular. the Department of Veterans Affairs, the terms and conditions of 35 U.S.C.
Affected Public: Individuals; Office of Research and Development, 209 and 37 CFR 404.7.
Businesses or other for-profit. intends to grant to Rubicon Signing Authority
Estimated Number of Respondents: Biotechnology, LLC, 26212 Dimension
Dr. Suite 260, Lake Forest, CA 92630, The Secretary of Veterans Affairs, or
399.
USA, an exclusive license to practice designee, approved this document and
Estimated Frequency of Response: On
the following: U.S. Patent Application authorized the undersigned to sign and
occasion.
Serial No. 13/815,829 (‘‘ANTIBODY- submit the document to the Office of the
Estimated Total Annual Burden:
MEDIATED TRANSDUCTION OF HEAT Federal Register for publication
2,315 hours.
SHOCK PROTEINS INTO LIVING electronically as an official document of
Comments submitted in response to the Department of Veterans Affairs. Jose
this notice will be summarized and CELLS’’), filed March 15, 2013, which
claimed the priority of U.S. Serial No. D. Riojas, Chief of Staff, approved this
included in the request for OMB document on March 2, 2015 for
approval. All comments will become a 61/618,594, filed March 30, 2012.
Copies of the published patent publication.
matter of public record. Comments are
invited on: applications may be obtained from the Approved: March 3, 2015.
(a) Whether the collection of U.S. Patent and Trademark Office at Michael Shores,
information is necessary for the proper www.uspto.gov. Regulation Policy and Management, Office
performance of the functions of the DATES: Comments must be received 15 of General Counsel.
OCC, including whether the information days from the date of this published [FR Doc. 2015–05209 Filed 3–5–15; 8:45 am]
has practical utility; Notice. BILLING CODE 8320–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES

VerDate Sep<11>2014 18:59 Mar 05, 2015 Jkt 235001 PO 00000 Frm 00125 Fmt 4703 Sfmt 9990 E:\FR\FM\06MRN1.SGM 06MRN1

Document Created: 2018-02-21 09:33:21
Document Modified: 2018-02-21 09:33:21

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of Intent.
Dates		Comments must be received 15 days from the date of this published Notice.
Contact		Dr. Lee A. Sylvers, Technology Transfer Specialist, Office of Research and Development (10P9TT), Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC, 20420, (202) 443-5646 (this is not a toll-free number).
FR Citation		80 FR 12262